Top Markets
Coin of the day
Medios AG Medios AG

Medios AG

ILM1
Classifica tra le azioni #15685
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Prezzo delle azioni
$13.21
Capitalizzazione di mercato
$337.03M
Variazione (1 giorno)
-0.36%
Variazione (1 anno)
-28.32%
Paese
DE
Scambia Medios AG (ILM1)

Categoria

Storico del rendimento da dividendi per Medios AG (ILM1)
Il rendimento da dividendi (TTM) di Medios AG (simbolo azionario: ILM1) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Medios AG (ILM1) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti